未找到相关数据
Adjuvant nab-paclitaxel plus S-1 versus oxaliplatin plus capecitabine after curative D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase 3 open-label, randomized controlled trial
被引：0
作者：
Yu Pengfei
Du, Yian
Xu, Zhiyuan
Yang, Litao
Ying, Jieer
Chen, Ping
Wei, Yunhai
Wu, Yingjie
Yan, Zhilong
Xu, Hongtao
Zhang, Xiaojing
Li, Yong
Zheng, Zhichao
Chen, Zhiheng
Cheng, Xiangdong
机构：
[1] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Ningbo Second Hosp, Ningbo, Peoples R China
[3] Zhejiang Univ, Huzhou Hosp, Huzhou Cent Hosp, Huzhou, Peoples R China
[4] Ningbo Univ, Affiliated Peoples Hosp, Ningbo, Peoples R China
[5] Ningbo First Hosp, Ningbo, Peoples R China
[6] Lishui Cent Hosp, Lishui, Peoples R China
[7] Huzhou Teachers Coll, Affiliated Hosp, 1 Peoples Hosp Huzhou, Huzhou, Peoples R China
[8] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[9] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[10] First Hosp Jiaxing, Jiaxing, Peoples R China
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
386
引用
收藏
页码：386 / 386
页数：1
相关论文